Skip to main content
Journal cover image

Peginterferon Lambda-1a (Lambda) is less likely to induce clinically significant neuropsychiatric symptoms during the treatment of chronic hepatitis C virus (HCV) infection, compared to peginterferon alfa-2a (Alfa)

Publication ,  Conference
Muir, AJ; Srinivasan, S; Sapra, S; Dimitrova, D; Hillson, JL; Lopez-Talavera, JC
Published in: HEPATOLOGY
October 1, 2012

Duke Scholars

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2012

Volume

56

Start / End Page

578A / 579A

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Muir, A. J., Srinivasan, S., Sapra, S., Dimitrova, D., Hillson, J. L., & Lopez-Talavera, J. C. (2012). Peginterferon Lambda-1a (Lambda) is less likely to induce clinically significant neuropsychiatric symptoms during the treatment of chronic hepatitis C virus (HCV) infection, compared to peginterferon alfa-2a (Alfa). In HEPATOLOGY (Vol. 56, pp. 578A-579A). Boston, MA: WILEY-BLACKWELL.
Muir, Andrew J., Subasree Srinivasan, Sandhya Sapra, Dessislava Dimitrova, Jan L. Hillson, and Juan Carlos Lopez-Talavera. “Peginterferon Lambda-1a (Lambda) is less likely to induce clinically significant neuropsychiatric symptoms during the treatment of chronic hepatitis C virus (HCV) infection, compared to peginterferon alfa-2a (Alfa).” In HEPATOLOGY, 56:578A-579A. WILEY-BLACKWELL, 2012.
Journal cover image

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2012

Volume

56

Start / End Page

578A / 579A

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics